高等学校化学学报

• 研究简报 • 上一篇    下一篇

有机小分子电致发光器件的蓝光主体材料的合成与表征

王志强1,2, 刘红梅1,2, 郑才俊1,2, 万婧1,2, 彭北快3, 张晓宏1   

    1. 中国科学院理化技术研究所纳米有机光电子实验室, 北京 100080;
    2. 中国科学院研究生院, 北京 100039;
    3. 北京联合大学生物化学工程学院, 北京 100023
  • 收稿日期:2007-03-06 修回日期:1900-01-01 出版日期:2007-11-10 发布日期:2007-11-10
  • 通讯作者: 张晓宏

Synthesis and Characterization of a New Small Organic Molecules Blue-Light Emitting Host Materials Suitable for Solution Process

WANG Zhi-Qiang1,2, LIU Hong-Mei1,2, ZHENG Cai-Jun1,2, WAN Jing1,2, PENG Zhao-Kuai3, ZHANG Xiao-Hong1*   

    1. Nano-organic Photoelectronic Laboratory, Technical Institute of Physics and Chemistry of CAS, Beijing 100080, China;
    2. Graduate School of Chinese Academy of Sciences, Beijing 100039, China;
    3. Bio-Chemical Engineering College of Beijing Union University, Beijing 100023, China
  • Received:2007-03-06 Revised:1900-01-01 Online:2007-11-10 Published:2007-11-10
  • Contact: ZHANG Xiao-Hong

摘要: 报道了应用于溶液法制备器件的小分子蓝光主体材料2-叔丁基-9,10-二(9,9-二正丙基芴基)蒽(TBPFA), 合成路线如Scheme 1所示, 该化合物具有较高的荧光量子效率,以它作为主体材料, 采用旋涂法制备了掺杂与非掺杂型单层器件, 并对器件性能进行了初步研究.

关键词: 有机电致发光器件(OLEDs), 溶液法, 蓝光主体材料, 蒽衍生物

Abstract: The current trend for fabricating OLEDs is solution processing in the scope for low-cost manufacturing, but most small organic molecules must be deposited in vacuum to fabricate devices due to their poor solubility. In this paper, a new soluble anthracene derivative 2-tert-butyl-9,10-bis(9,9-dipropylfluorenyl)anthracene(TBPFA) was designed and synthesized. The compound exhibited pure-blue-light emitting(λmax=443 nm in dilute dichloromethane, λmax=450 nm in solid film) and high fluorescence quantum efficiency. The none-doped and doped single-layer devices were prepared successfully by spin coating process with TBPFA as blue-light emitting material and blue-light emitting host material respectively. In the doped device, TBPFA can transport energies to TBPe which is a good blue-light emitting material efficiently.

Key words: OLEDs, Solution process, Blue-light emitting host material, Anthracene derivative

中图分类号: 

TrendMD: